These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 29297597

  • 1. Validation of a Novel Scoring System for Changes in Skeletal Manifestations of Hypophosphatasia in Newborns, Infants, and Children: The Radiographic Global Impression of Change Scale.
    Whyte MP, Fujita KP, Moseley S, Thompson DD, McAlister WH.
    J Bone Miner Res; 2018 May; 33(5):868-874. PubMed ID: 29297597
    [Abstract] [Full Text] [Related]

  • 2. Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a single-arm, open-label, phase 2 extension trial.
    Whyte MP, Simmons JH, Moseley S, Fujita KP, Bishop N, Salman NJ, Taylor J, Phillips D, McGinn M, McAlister WH.
    Lancet Diabetes Endocrinol; 2019 Feb; 7(2):93-105. PubMed ID: 30558909
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and Safety of Asfotase Alfa in Infants and Young Children With Hypophosphatasia: A Phase 2 Open-Label Study.
    Hofmann CE, Harmatz P, Vockley J, Högler W, Nakayama H, Bishop N, Martos-Moreno GÁ, Moseley S, Fujita KP, Liese J, Rockman-Greenberg C, ENB-010-10 Study Group.
    J Clin Endocrinol Metab; 2019 Jul 01; 104(7):2735-2747. PubMed ID: 30811537
    [Abstract] [Full Text] [Related]

  • 4. Dual X-ray absorptiometry has limited utility in detecting bone pathology in children with hypophosphatasia: A pooled post hoc analysis of asfotase alfa clinical trial data.
    Simmons JH, Rush ET, Petryk A, Zhou S, Martos-Moreno GÁ.
    Bone; 2020 Aug 01; 137():115413. PubMed ID: 32417537
    [Abstract] [Full Text] [Related]

  • 5. Asfotase alfa therapy for children with hypophosphatasia.
    Whyte MP, Madson KL, Phillips D, Reeves AL, McAlister WH, Yakimoski A, Mack KE, Hamilton K, Kagan K, Fujita KP, Thompson DD, Moseley S, Odrljin T, Rockman-Greenberg C.
    JCI Insight; 2016 Jun 16; 1(9):e85971. PubMed ID: 27699270
    [Abstract] [Full Text] [Related]

  • 6. Five-year efficacy and safety of asfotase alfa therapy for adults and adolescents with hypophosphatasia.
    Kishnani PS, Rockman-Greenberg C, Rauch F, Bhatti MT, Moseley S, Denker AE, Watsky E, Whyte MP.
    Bone; 2019 Apr 16; 121():149-162. PubMed ID: 30576866
    [Abstract] [Full Text] [Related]

  • 7. No vascular calcification on cardiac computed tomography spanning asfotase alfa treatment for an elderly woman with hypophosphatasia.
    Whyte MP, McAlister WH, Mumm S, Bierhals AJ.
    Bone; 2019 May 16; 122():231-236. PubMed ID: 30825650
    [Abstract] [Full Text] [Related]

  • 8. Hypophosphatasia: From Diagnosis to Treatment.
    Simon S, Resch H, Klaushofer K, Roschger P, Zwerina J, Kocijan R.
    Curr Rheumatol Rep; 2018 Sep 10; 20(11):69. PubMed ID: 30203264
    [Abstract] [Full Text] [Related]

  • 9. Hypophosphatasia: Enzyme Replacement Therapy Brings New Opportunities and New Challenges.
    Whyte MP.
    J Bone Miner Res; 2017 Apr 10; 32(4):667-675. PubMed ID: 28084648
    [Abstract] [Full Text] [Related]

  • 10. Asfotase Alfa: A Review in Paediatric-Onset Hypophosphatasia.
    Scott LJ.
    Drugs; 2016 Feb 10; 76(2):255-62. PubMed ID: 26744272
    [Abstract] [Full Text] [Related]

  • 11. Asfotase Alfa Treatment Improves Survival for Perinatal and Infantile Hypophosphatasia.
    Whyte MP, Rockman-Greenberg C, Ozono K, Riese R, Moseley S, Melian A, Thompson DD, Bishop N, Hofmann C.
    J Clin Endocrinol Metab; 2016 Jan 10; 101(1):334-42. PubMed ID: 26529632
    [Abstract] [Full Text] [Related]

  • 12. Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa.
    Kishnani PS, Rush ET, Arundel P, Bishop N, Dahir K, Fraser W, Harmatz P, Linglart A, Munns CF, Nunes ME, Saal HM, Seefried L, Ozono K.
    Mol Genet Metab; 2017 Sep 10; 122(1-2):4-17. PubMed ID: 28888853
    [Abstract] [Full Text] [Related]

  • 13. Recovery of bone mineralization and quality during asfotase alfa treatment in an adult patient with infantile-onset hypophosphatasia.
    Rolvien T, Schmidt T, Schmidt FN, von Kroge S, Busse B, Amling M, Barvencik F.
    Bone; 2019 Oct 10; 127():67-74. PubMed ID: 31152801
    [Abstract] [Full Text] [Related]

  • 14. Enzyme Replacement Therapy in Hypophosphatasia.
    Uçaktürk SA, Elmaogullari S, Ünal S, Gönülal D, Mengen E.
    J Coll Physicians Surg Pak; 2018 Sep 10; 28(9):S198-S200. PubMed ID: 30173697
    [Abstract] [Full Text] [Related]

  • 15. Profile of asfotase alfa in the treatment of hypophosphatasia: design, development, and place in therapy.
    Bowden SA, Foster BL.
    Drug Des Devel Ther; 2018 Sep 10; 12():3147-3161. PubMed ID: 30288020
    [Abstract] [Full Text] [Related]

  • 16. Safety and efficacy of treatment with asfotase alfa in patients with hypophosphatasia: Results from a Japanese clinical trial.
    Kitaoka T, Tajima T, Nagasaki K, Kikuchi T, Yamamoto K, Michigami T, Okada S, Fujiwara I, Kokaji M, Mochizuki H, Ogata T, Tatebayashi K, Watanabe A, Yatsuga S, Kubota T, Ozono K.
    Clin Endocrinol (Oxf); 2017 Jul 10; 87(1):10-19. PubMed ID: 28374482
    [Abstract] [Full Text] [Related]

  • 17. Asfotase alfa: enzyme replacement for the treatment of bone disease in hypophosphatasia.
    Hofmann C, Seefried L, Jakob F.
    Drugs Today (Barc); 2016 May 10; 52(5):271-85. PubMed ID: 27376160
    [Abstract] [Full Text] [Related]

  • 18. Validation of the Radiographic Global Impression of Change (RGI-C) score to assess healing of rickets in pediatric X-linked hypophosphatemia (XLH).
    Lim R, Shailam R, Hulett R, Skrinar A, Nixon A, Williams A, Nixon M, Thacher TD.
    Bone; 2021 Jul 10; 148():115964. PubMed ID: 33878504
    [Abstract] [Full Text] [Related]

  • 19. Healthcare resource utilization in the management of hypophosphatasia in three patients displaying a spectrum of manifestations.
    Daniel AB, Saraff V, Shaw NJ, Yates R, Mughal MZ, Padidela R.
    Orphanet J Rare Dis; 2018 Aug 16; 13(1):142. PubMed ID: 30115096
    [Abstract] [Full Text] [Related]

  • 20. Asfotase alfa treatment for 1 year in a 16 year-old male with severe childhood hypophosphatasia.
    Bowden SA, Adler BH.
    Osteoporos Int; 2018 Feb 16; 29(2):511-515. PubMed ID: 29046930
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.